Company
Headquarters: Guangzhou, China
Employees: 2,657
CN¥5.68 Billion
CNY as of July 1, 2025
US$792.4 Million
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $309.91 B |
| Vertex Pharmaceuticals Incorporated | $117.36 B |
| CSL Limited | $95.75 B |
| Regeneron Pharmaceuticals, Inc. | $59.14 B |
| Marinomed Biotech AG | $58.56 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $699.59 B |
| Johnson & Johnson | $374.29 B |
| AbbVie | $336.94 B |
| Novo Nordisk | $309.91 B |
| UnitedHealth Group | $279.90 B |
Chempartner Pharmatech Co., Ltd. engages in the microecological nutrition and healthcare businesses worldwide. The company provides medical contract research organization, and contract development and manufacturing organization services for pre-clinical stages. It is also involved in the research, production, and sales of prebiotic fibers as a microecological fortification ingredient, ODM product, and food for special medical purposes product. The company was formerly known as Quantum Hi-Tech (China) Biological Co., Ltd. and changed its name to Quantum Hi-Tech (China) Biological Co., Ltd. in September 2020. Quantum Hi-Tech (China) Biological Co., Ltd. was founded in 2000 and is headquartered in Guangzhou, China.
Chempartner Pharmatech Co. Ltd has the following listings and related stock indices.
Stock: SZSE: 300149 wb_incandescent